In October, short interest increased from 65,000 shares to 448,000 shares. it will be interesting to see the short interest for the period 11/1 to 11/15.
Today, the stock filled a gap up that occured on 9/25 when the stock opened at $9.98 up from the previous day close of $9.38.
Just over a week ago the company had a very strong quarterly conference call in which they indicated that their spy equipment is now located in over 600 hospitals, that all of their partnership arrangments are progressing smoothly, and that Pinpoint is progressing well. There was nothing in the earnings or CC presentation that would justify this sharp reduction in the pps. The only possible negative is that since Obama was reelected, Obamacare is here to stay, and with that comes the additional tax on the sale of medical devices.
regards endo